Nanobiotechnology as an emerging approach to combat malaria: A systematic review.
Biosynthesized nanoparticles
Larvicidal activity
Malaria
Plasmodium
Vector
Journal
Nanomedicine : nanotechnology, biology, and medicine
ISSN: 1549-9642
Titre abrégé: Nanomedicine
Pays: United States
ID NLM: 101233142
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
10
09
2018
revised:
01
02
2019
accepted:
15
02
2019
pubmed:
25
3
2019
medline:
4
12
2019
entrez:
25
3
2019
Statut:
ppublish
Résumé
Mosquitoes (Diptera; Culicidae) present a major threat to millions of people and animals worldwide, as they act as vectors for various pathogens, especially parasites and viruses. Resistance to insecticides, such as organophosphates and microbial control agents, and insufficient adherence to application guidelines are common reasons for insecticide treatment failure. Therefore, there is an urgent need for exploration of safer, cheaper, and more effective agents, with novel modes of action, to improve mosquito control. Biosynthesized nanoparticles (NPs) have recently been considered as a potential approach for combating vectors of malaria and also as a treatment for malaria. Here, we present current knowledge about the characterization and effectiveness of biogenic NPs against major vectors of malaria, including avian malaria (which may also provide useful insights on vectors of human malaria). This article is the first systematic review of the effects of biosynthesized nanoparticles on both malaria parasites (Plasmodium spp.) and relevant vectors.
Identifiants
pubmed: 30904586
pii: S1549-9634(19)30048-6
doi: 10.1016/j.nano.2019.02.017
pii:
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
221-233Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.